Abstract-The goal of this study was to determine whether hypoxia alters expression of endothelial nitric oxide synthase (eNOS) in the systemic circulation. Rats breathed either air or 10% oxygen for 12 hours, 48 hours, or 7 days. Thoracic aortas were excised and either mounted in organ bath myographs or frozen in liquid nitrogen for later extraction of protein and RNA. eNOS protein (Western blotting) was decreased (20% of normoxic control) after 12 hours, 48 hours, and 7 days of hypoxia. eNOS mRNA (ribonuclease protection assay) was similarly reduced. Acetylcholine (10 Ϫ4 mol/L) reversed phenylephrine (10 Ϫ5 mol/L) preconstriction by 53.3Ϯ5.6% in aortic rings from normoxic rats and 26.1Ϯ4.8% in rings from rats exposed to hypoxia for 48 hours (PϽ0.05), with comparable impairment of relaxation by the calcium ionophore A23187 (10 Ϫ5 mol/L). Responses to diethylamine nitric oxide and 8-bromo-cGMP were unaffected. Aortic cGMP levels after incubation with acetylcholine (10 Ϫ6 mol/L) averaged 14.0Ϯ1.8 fmol/mg in rings from normoxic rats compared with 8.7Ϯ1.0 fmol/mg in rings from hypoxic rats (PϽ0.05). Similarly, nitrate concentration (by capillary electrophoresis) in the media in which the rings were incubated was reduced in the hypoxic group (5.6Ϯ0.23 mol/L for hypoxic rats and 7.8Ϯ0.7 mol/L for normoxic rats). Impaired endothelial NO release may handicap the vascular responses that defend vital organ function during hypoxia. (Circ Res. 2000;86:671-675.) Key Words: endothelium Ⅲ systemic vasculature Ⅲ hypoxic vasodilation Ⅲ autoregulation H ypoxia occurs commonly in patients with cardiopulmonary diseases and in normal individuals at high altitude. Survival under these conditions requires adaptive responses from the systemic circulation that redistribute the available oxygen supply toward vital organs 1 and enhance oxygen extraction. 2 Many of the mechanisms that mediate these responses are localized to the vascular endothelium. In particular, endothelial release of nitric oxide (NO) has been shown to modulate myogenic autoregulatory responses 3 and to mediate flow dilation of resistance arterioles 4 ; active hyperemia 5 ; reactive hyperemia 6 ; and, in some vascular beds, hypoxic vasodilation. 7 Thus, a central role is emerging for endothelial production of NO in maintaining the balance between tissue oxygen supply and metabolic demand. If expression of endothelial nitric oxide synthase (eNOS), the enzyme that catalyzes NO synthesis, is regulated by oxygen tension, changes in the capacity for endothelial NO release may either be an important adaptive response or else contribute to the pathogenesis of vital organ failure, depending on whether it is enhanced or impaired, respectively.
H ypoxia occurs commonly in patients with cardiopulmonary diseases and in normal individuals at high altitude. Survival under these conditions requires adaptive responses from the systemic circulation that redistribute the available oxygen supply toward vital organs 1 and enhance oxygen extraction. 2 Many of the mechanisms that mediate these responses are localized to the vascular endothelium. In particular, endothelial release of nitric oxide (NO) has been shown to modulate myogenic autoregulatory responses 3 and to mediate flow dilation of resistance arterioles 4 ; active hyperemia 5 ; reactive hyperemia 6 ; and, in some vascular beds, hypoxic vasodilation. 7 Thus, a central role is emerging for endothelial production of NO in maintaining the balance between tissue oxygen supply and metabolic demand. If expression of endothelial nitric oxide synthase (eNOS), the enzyme that catalyzes NO synthesis, is regulated by oxygen tension, changes in the capacity for endothelial NO release may either be an important adaptive response or else contribute to the pathogenesis of vital organ failure, depending on whether it is enhanced or impaired, respectively.
The effect of hypoxic incubation on eNOS expression has been investigated previously in endothelial cells in culture. 8 -10 Unfortunately, the results of these studies have varied in both direction and magnitude. Despite its fundamental clinical and physiological relevance, therefore, the question of whether a change in eNOS availability alters vasoregulatory responses during hypoxia remains unanswered. Accordingly, the current study was undertaken to determine whether exposure to hypoxia in vivo alters expression of eNOS protein and mRNA in the systemic vasculature and to evaluate the effect of this change on endotheliumdependent vasorelaxation.
Materials and Methods
Male Sprague-Dawley rats were exposed to either normoxia or hypoxia (10% O 2 ) for 12 hours, 48 hours, or 7 days.
Western Blot
Proteins from thoracic aorta and lung were analyzed using an eNOS-specific monoclonal antibody (Transduction Laboratories).
cDNA cloning
Aortic RNA was extracted using TRIzol. 11 One microgram of RNA was reverse transcribed, and an 871-bp eNOS cDNA was amplified by polymerase chain reaction (PCR) using sense (5Ј-AGCTGGCATGGGCAACTTGAA-3Ј) and antisense (5Ј-CAGCACATCAAAGCGGCCATT-3Ј) primers and subcloned into the PCRII vector (Invitrogen) behind the T7 promoter (GenBank accession No. AF085195). ␤-Actin cDNA (292 bp) was also amplified by PCR (sense, 5Ј-AAGTACCCCATTGAACACGGCA-3Ј; antisense, 5Ј-TAGATGGGCACAGTGTGGGTGA-3Ј) and subcloned into the PCRII vector (Invitrogen) behind the Sp6 promoter (GenBank accession No. AF122903).
P-Labeled Riboprobe Synthesis and Ribonuclease Protection Assay
eNOS and ␤-actin constructs were linearized with BamHI and Bsu36I, respectively. Antisense RNA for eNOS and ␤-actin were synthesized using T7 and Sp6 RNA polymerases, respectively, from 1 g of linearized construct and ␣-32 P-labeled CTP (Amersham). The eNOS cRNA spanned regions homologous to exons 4 to 7 of the human eNOS sequence. 12 The ␤-actin probe spanned exons 3 and 4 of the rat ␤-actin gene. Ribonuclease protection assays for eNOS and ␤-actin were carried out simultaneously on aortic RNA from each of the rats in each group. Protected mRNA was quantified by densitometry.
Endothelium-Dependent and -Independent Relaxation
Aortic segments (4 mm) from normoxic rats and rats exposed to hypoxia for 48 hours were treated with 10 Ϫ5 mol/L phenylephrine. Concentration-response curves for acetylcholine (Ach; 10 Ϫ9 to 10 Ϫ4 mol/L) were generated, and maximum relaxations in response to A23187 (10 Ϫ5 mol/L), diethylamine nitric oxide (DEA/NO, 10
Ϫ4
mol/L), and 8-bromo-cGMP (8-Br-cGMP, 10 Ϫ4 mol/L) were assessed.
cGMP Radioimmunoassay
Aortic segments (2 mm) from normoxic and 48-hour hypoxic rats were incubated at 37°C for 1 hour in Krebs solution, for 10 minutes in isobutylmethylxanthine (0.5 mmol/L), and then with Ach (10 Ϫ6 mol/L) for 1 or 4 minutes or for 1 minute in the absence of Ach. The reaction was stopped with trichloroacetic acid (10% wt/vol). Trichloroacetic acid was removed with water-saturated ether, and the samples were acetylated with a 2:1 mixture of trifluoroethane and glacial acetic acid. The samples were incubated with a rabbit anti-rat cGMP antibody for 48 hours before overnight incubation with 125 I-labeled cGMP. Rabbit serum and IgG were added, the samples were precipitated with 12.5% polyethylene glycol, and radioactivity was measured with a gamma counter.
Capillary Electrophoresis (CE)
Plasma nitrate (NO 3 Ϫ ) concentration was measured by CE. 13, 14 Plasma was collected from normoxic and 48-hour hypoxic rats, filtered (0.2 m), and analyzed in a 50 mmol/L phosphate buffer (pH 2.5) with 0.5 mmol/L spermine using an ABI270 CE instrument with a 50-m fused silica capillary (Polymicro Technologies). Samples were separated at Ϫ347 Vcm Ϫ1 (45 to 50 A) at 30°C, and the NO 3 Ϫ peak was detected by absorption at 214 nm. Nitrate concentration was also measured in the reaction media from unstimulated and Ach-stimulated (4 minutes) aortic segments. Calibration curves were constructed with plasma or reaction media spiked with standard nitrate solutions. An expanded Materials and Methods section is available online at http://www.circresaha.org.
Results eNOS Protein
Representative Western blots conducted on proteins from thoracic aortas and lungs from a normoxic rat and rats exposed to hypoxia for 12 hours, 48 hours, and 7 days are illustrated in Figures 1A and 1B , respectively. The accompanying histograms illustrate the mean aortic and lung eNOS protein levels (arbitrary units of optical density) for each group (nϭ4 per group). Aortic eNOS protein was decreased (PϽ0.01 versus normoxic controls) after 12 hours, 48 hours, and 7 days of hypoxia. Lung eNOS protein levels were unchanged after 12 and 48 hours of hypoxia but were increased (PϽ0.05 versus normoxic controls) after 7 days of hypoxia, as previously reported. 19 -21 eNOS mRNA A representative autoradiogram of an RNase protection assay carried out on aortic RNA from a normoxic rat and from rats exposed to hypoxia for 12 hours, 48 hours, and 7 days is illustrated in the top panel of Figure 2 . The histogram in the lower panel illustrates the mean aortic eNOS mRNA levels in each group (nϭ5 per group) expressed as a percentage of the ␤-actin mRNA level. Aortic eNOS mRNA levels were decreased (PϽ0.01) after exposure to hypoxia for 12 hours, 48 hours, and 7 days compared with normoxic controls.
Endothelium-Dependent and -Independent Relaxation
The concentration-response relationships for Ach-induced relaxation in aortic rings from normoxic rats and from rats exposed to hypoxia for 48 hours are illustrated in the top panel of Figure 3 . The tension generated during contraction with 10 Ϫ5 mol/L phenylephrine was 1.67 Ϯ 0.08 g/mg dry weight in rings from normoxic rats. As has been reported previously, 24 tension was lower (0.88Ϯ0.06 g/mg dry weight) in rings from hypoxic rats. Maximal relaxation by Ach was 53.3Ϯ5.6% of the phenylephrine-induced contraction in rings from normoxic rats, compared with 26.1Ϯ4.8% in rings from rats exposed to hypoxia (PϽ0.05 for difference). The pEC 50 for Ach-induced relaxation was 6.90Ϯ0.18 in rings from normoxic rats and 7.21Ϯ0.14 in rings from hypoxic rats (PϾ0.05).
The responses to A23187, DEA/NO, and 8-Br-cGMP in aortic rings from normoxic rats and from rats exposed to hypoxia for 48 hours are compared in the bottom panel of Figure 3 . Relaxation of phenylephrine contraction by A23187 was reduced in the hypoxic group. The responses to DEA/NO and 8-Br-cGMP in aortic rings from hypoxic rats did not differ from those in rings from normoxic rats. In this group, Ach reversed 48.5Ϯ3.8% of the phenylephrine-induced contraction in rings from normoxic rats and 20.1Ϯ2.8% in rings from rats exposed to hypoxia (PϽ0.05 for difference).
cGMP Generation
The effect of hypoxia on aortic cGMP levels during in vitro stimulation with Ach is illustrated in Figure 4 . Unstimulated cGMP levels did not differ between normoxic rats and those exposed to hypoxia for 48 hours. The mean aortic cGMP level after 4 minutes of incubation with Ach was lower (PϽ0.05) in the group exposed to hypoxia for 48 hours than in the normoxic group.
Plasma Nitrate Concentration and Aortic Nitrate Production
Concentrations of NO 3 Ϫ in plasma from normoxic rats (nϭ7) and from rats exposed to hypoxia for 48 hours (nϭ6) averaged 70.3Ϯ2.6 and 72.1Ϯ5.2 mol/L, respectively (PϾ0.05 for difference). The concentrations of nitrate in the reaction buffer from aortic rings from normoxic rats and from rats exposed to hypoxia for 48 hours that were not treated with Ach (control) and that were incubated with 10 Ϫ6 mol/L Ach for 4 minutes are illustrated in Figure 5 . Unstimulated values in the two groups did not differ. Nitrate concentrations were higher (PϽ0.05) after incubation with Ach in the normoxic than in the hypoxic group.
Discussion
The results of this study indicate that in rats, prolonged exposure to hypoxia results in (1) a decrease in aortic eNOS protein and mRNA, (2) impaired endothelium-dependent relaxation of phenylephrine-precontracted aortic rings, and (3) impaired capacity of aortic segments to generate cGMP and NO 3 Ϫ in response to stimulation by Ach. This is the first demonstration that physiologically relevant levels of hypoxia in vivo alter eNOS expression in the systemic vasculature and, consequently, impair endothelium-dependent vascular responses. Our finding that, after exposure to hypoxia, relaxation in response to A23187 is decreased to a similar extent as relaxation to Ach points to an abnormality distal to events occurring at the level of the endothelial cell plasma membrane (ie, Ach receptor activation and Ca 2ϩ entry). The alteration must also be upstream of soluble guanylate cyclase activation or cGMP target sites, because the relaxant effects of DEA/NO, and 8-br-cGMP were not affected. The abnormality in endothelium-dependent relaxation after in vivo hypoxia, therefore, is not due to the inability to activate eNOS or to respond to its product (NO), but rather to a reduction in the availability of this enzyme.
Previous studies of the effects of hypoxia on eNOS protein and mRNA expression in cultured endothelial cells have yielded conflicting results. Hypoxic incubation (0% O 2 for 24 hours) decreased eNOS protein and mRNA in endothelial cells from human umbilical 8 and saphenous 15, 16 veins and from bovine pulmonary artery 9 and aorta. 9, 15 In contrast, Arnet et al 10 reported that eNOS protein and mRNA were increased in bovine aortic endothelial cells after 24 hours of incubation at 1% O 2 . Moreover, a luciferase reporter construct consisting of the eNOS 5Ј regulatory region could be activated in these cells by hypoxia. Upregulation of eNOS protein and activity has also been demonstrated in earlypassage porcine coronary arteriolar endothelial cells after hypoxic exposures of 30 to 240 minutes' duration. 17 This variability reflects differences in the species and vascular bed from which the endothelial cells were derived, the methods used to maintain the cells, and the duration and severity of the hypoxic exposures. Even if the previous data were consistent, however, cell culture experiments may not accurately reproduce the microenvironment to which these cells are normally exposed nor the chemical and mechanical stimuli that interact with the effects of hypoxia under physiological conditions. Convincing evidence that hypoxic regulation of eNOS protein expression is a physiologically relevant mechanism, therefore, requires its demonstration in vivo, and the present results complement and extend the findings of the previous studies.
The effect of in vivo exposure to hypoxia on eNOS protein expression has previously been investigated in the rat pulmonary circulation. 18 -20 In those studies, breathing 10% oxygen for 7 days and for 3 weeks increased pulmonary eNOS levels. This could not be attributed to the known stimulatory effect of increased flow (shear stress) on eNOS expression, 21 because inhibiting the increase in pulmonary blood flow by surgical stenosis of the pulmonary artery failed to prevent the increases in eNOS. Our present results confirm upregulation of lung eNOS protein after 7 days of hypoxia and demonstrate that hypoxia has the opposite effect on eNOS expression in the aorta.
Aortic blood flow is also increased in rats during hypoxia. 1 Although shear stress at the endothelial-luminal interface may not necessarily increase in tandem with flow, it is highly unlikely to change in the opposite direction. Consequently, the decrease in aortic eNOS that we describe in this report is not likely to be attributable to changes in flow. This study does not include experiments designed to dissociate the influence of other hemodynamic or neurohumoral stimuli from the direct effects of hypoxia. Nonetheless, these factors compose part of the response to systemic hypoxia, and the hypoxic exposures as presented in this study simulate a clinically and physiologically relevant condition. Taken together, our current results and those of previous in vivo studies indicate marked regional variability in eNOS protein expression during systemic hypoxia.
The endothelium normally exerts an inhibitory effect on vascular reactivity, and agonist-induced contraction is greater in arterial segments from which the endothelium has been removed compared with those in which it is intact. 22, 23 In previous studies, we have noted that, after prolonged hypoxic exposure, endothelial ablation resulted in a decrease rather than an increase in the contractile response of rat aortic segments to phenylephrine. 23 After hypoxia, therefore, the endothelium serves as a source of substances that enhance rather than inhibit contraction. Our current results provide a partial mechanistic explanation for this finding, because the inhibitory influence of the endothelium on vascular reactivity has been attributed to endothelial NO release. 22 A decreased capacity for vasodilator synthesis, however, cannot account for endothelial enhancement of contractility, and a concomitant increase in endothelium-derived constricting factor release must be proposed. Synthesis and receptor binding of both endothelin-1 24, 25 and thromboxane A 2 26,27 have been reported to be under the negative regulatory influence of NO. Accordingly, hypoxic inhibition of eNOS expression may play an additional role in the alteration in endothelial function through the removal of an inhibitor of vasoconstrictor production and activity.
Plasma nitrate levels did not differ between normoxic rats and rats exposed to hypoxia for 48 hours in the current study, indicating that factors other than aortic eNOS levels determine the circulating NO 3 Ϫ concentration. During hypoxia, Figure 5 . Nitrate concentrations in buffer from aortic rings from normoxic rats and rats exposed to hypoxia for 48 hours incubated in the presence and absence (control) of Ach (10 Ϫ6 mol/L). *PϽ0.05 for difference from the unstimulated control value; ϩPϽ0.05 for difference from corresponding value in the normoxic group. Data are meanϮSEM.
increased flow 1 will stimulate NO synthesis by the remaining enzyme, 28 the duration of eNOS activation may be increased as a result of increased pH of the endothelial intracellular space, 29, 30 and increased eNOS expression in the pulmonary circulation 18 may counterbalance the effect of decreased NO synthesis in the systemic vasculature. Our inability to demonstrate a decrease in circulating NO 3 Ϫ , therefore, does not diminish the pathophysiological significance of hypoxic inhibition of eNOS expression in the systemic circulation. The dilatory response to flow needed to maximize perfusion 4 and the decrease in transvascular resistance necessary to accommodate increased metabolic activity 5 and to preserve vital organ perfusion during superimposed hypotensive stresses 3 require that local NO production be intact. A decrease in the capacity of the endothelium to maximally respond to dilatory stimuli would undermine these responses.
Inhibition of NO synthesis by infusion of L-arginine analogues has been shown to inhibit hypoxic vasodilation in the guinea pig heart 7 and canine diaphragm. 31 In at least some essential vascular beds, therefore, this pathway must be intact to optimize perfusion and maintain tissue oxygenation in the face of decreased systemic oxygen delivery. These responses will be impaired by a reduction in the local capacity to produce NO. Because the decrease in eNOS protein expression occurs relatively quickly (hours to days), impaired endothelial NO release is relevant to cardiopulmonary diseases associated with hypoxia (eg, pneumonia, congestive heart failure, and exacerbations of chronic obstructive lung disease) of which the natural histories evolve over this time frame. Hypoxic inhibition of eNOS expression in the systemic circulation may, therefore, represent an important mechanism in the pathogenesis of organ dysfunction in critically ill patients.
